Astria Therapeutics, Inc. Shareholders' Equity
Astria Therapeutics, Inc. had Shareholders' Equity of $233.25 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-11-12
- 2025-09-30: Stockholders' Equity Attributable to Parent $233.25M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $260.51M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $289.29M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $319.26M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-09-30 | $233.25M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $260.51M 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $289.29M 10-Q · filed 2025-11-12 | |
| 2024-12-31 | $319.26M 10-Q · filed 2025-11-12 | |
| 2024-09-30 | $341.65M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $347.08M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $367.74M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $243.12M 10-Q · filed 2025-11-12 | |
| 2023-09-30 | $184.48M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $200.40M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $211.36M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $221.22M 10-K · filed 2025-03-11 | |
| 2022-09-30 | $112.87M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $99.42M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $109.69M 10-Q · filed 2023-11-13 | $109.69M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $122.31M 10-K · filed 2024-03-04 | |
| 2021-09-30 | $130.43M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $136.90M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | -$101.14M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $40.67M 10-K · filed 2023-03-22 | |
| 2020-09-30 | $49.31M 10-Q · filed 2021-11-10 | $49.31M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $50.86M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $53.71M 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $35.72M 10-K · filed 2022-03-10 | |
| 2019-09-30 | $38.27M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $43.36M 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $49.87M 10-Q · filed 2020-05-12 | |
| 2018-12-31 | $34.94M 10-K/A · filed 2021-04-19 | |
| 2018-09-30 | $40.52M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $45.81M 10-Q · filed 2019-08-08 | $45.81M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $12.93M 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $11.79M 10-K · filed 2020-03-10 | |
| 2017-09-30 | $15.66M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $21.55M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $23.95M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $29.09M 10-K · filed 2019-03-14 | |
| 2016-09-30 | $36.86M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $32.81M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $41.72M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $50.49M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $59.54M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $67.59M 10-Q · filed 2015-08-13 | |
| 2014-12-31 | -$73.05M 10-K · filed 2018-03-15 | |
| 2013-12-31 | -$52.18M 10-K · filed 2017-03-16 | |
| 2012-12-31 | -$34.44M 10-K · filed 2016-03-15 |